Michael Sela

Michael Sela
Michael Sela
מיכאל סלע
	Michael Sela
Born	Mieczysław Salomonowicz; 2 March 1924; Tomaszów Mazowiecki, Poland
Died	27 May 2022 (aged 98)
Nationality	Israeli
Occupation	immunologist
Known for	Research in immunology; President of the Weizmann Institute of Science;
Title	W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science
Awards	The Israel Prize in Life Sciences (1959); Germany's Otto Warburg Medal (1968); The Rothschild Prize (1968); Canada's Gairdner Foundation International Award (1980); Germany's Commander's Cross of the Order of Merit Award (1986); France's Officier de l'Ordre de la Légion d'honneur (1987); Interbrew-Baillet Latour Health Prize of Belgium (1997); The Wolf Prize in Medicine (1998);

Michael Sela (Hebrew: מיכאל סלע; Mieczysław Salomonowicz; 2 March 1924 – 27 May 2022) was a Polish-born Israeli immunologist. He was the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot. He was the president of the Weizmann Institute of Science from 1975 until 1985. He was probably best known as the co-developer (with Ruth Arnon and Dvora Teitelbaum) of the multiple sclerosis drug copaxone.

Sela died on 27 May 2022 at the age of 98.

References

This short article about a person or group of people can be made longer. You can help Wikipedia by adding to it.